test

Zhanping Wu

@Vivo Capital, Llc

Latest period2024 - Q3ReportedManaged Assets$1.208BTotal holdings43
Assets growth rate11.63%Assets growth rate (2-Q avg)-1.65%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Vivo Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 43 positions.

Assets under management

The assets under management (AUM) of Vivo Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.208B in assets, with a quarterly growth rate of 11.63% and a 2-quarter average growth rate of -1.65%. The portfolio is managed by Zhanping Wu, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
AVDLAvadel Pharmaceuticals Plc
Recent Activity
New Position
2.92%
$35.202M
2.684M shares@ $13.12 avg price
ZBIOZenas Biopharma Inc
Recent Activity
New Position
1.66%
$20.021M
1.183M shares@ $16.92 avg price
CRVSCorvus Pharmaceuticals Holdings
Recent Activity
New Position
0.66%
$7.906M
1.497M shares@ $5.28 avg price
TRVITrevi Therapeutics Inc
Recent Activity
New Position
0.45%
$5.387M
1.613M shares@ $3.34 avg price
ALGSAligos Therapeutics Inc
Recent Activity
New Position
0.11%
$1.229M
141,879 shares@ $8.66 avg price
TENXTenax Therapeutics Inc
Recent Activity
New Position
0.06%
$720,832
208,333 shares@ $3.46 avg price